Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
A Kaiser Permanente genetic analysis found 82 locations on the human genome associated with migraine, 48 of them newly identified, including 3 specific to women, who experience migraine much more frequently than men.
Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.
Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.
Using data from Kaiser Permanente and United Kingdom biobanks, researchers have identified new locations on the human genome that could relate to the risk of age-related cataract.
About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.
New Kaiser Permanente study finds continuous glucose monitors are associated with improved blood sugar control and fewer visits to the emergency room for hypoglycemia in type 2 diabetes patients treated with insulin.
Teens diagnosed with attention deficit hyperactivity disorder (ADHD) often don’t take their medication regularly, and new Kaiser Permanente research finds the problem gets worse when they hit adulthood. The study also related non-adherence to ADHD medication with some negative health and social outcomes.
Kaiser Permanente research scientist uses her expertise in epidemiology and nutrition to improve outcomes for cancer patients and enhance their survivorship.
A long-term study that has produced important insights into menopause and women’s health at midlife is starting its 27th year with new federal funding from the National Institute on Aging (NIA) at 7 sites including the Kaiser Permanente Division of Research in Oakland.
Andy Avins, MD, MPH, has been studying what works, and what doesn't, in medical care ever since a chance encounter in the hospital library with a journal that introduced him to the concept of evidence-based medicine.